59 results about "Symptom improvement" patented technology

The invention provides a traditional Chinese medicine composition for treating rheumatoid arthritis, which is formulated according to Jun Chen Zuo Shi. The formula is: Monarch medicine: drynaria 18, psoralen 12, rehmannia glutinosa 15, epimedium 12, antler slices or antler glue 12; ministerial medicine: notopterygium 12, dog ridge 30, chuanduan 18, solitary living 10 , eucommia 20, yam 12, angelica 12, chuanxiong 9, white peony root 12, roasted ephedra 6, dried ginger 6, clematis 15, windproof 12, white silkworm 12, raw barley 30; cassia twig 9; adjuvant medicines are: Zhishanjia 6, Atractylodes macrocephala 10, Radix Astragali 50; According to the diagnostic criteria revised by the American College of Rheumatology in 1987, 30% of the symptoms were completely improved, 33% were markedly improved, 30% were improved, 7% were not improved, and the total improvement rate was about 93%. The curative effect is exact and the treatment effect is good.

The invention discloses a traditional Chinese medicine data processing device and method. The method comprises the steps of reading clinical traditional Chinese medicine case data and obtaining traditional Chinese medicine dose data and symptom degree data of all visits in the case data; carrying out normalization processing on the traditional Chinese medicine dose data to obtain standardized traditional Chinese medicine dose data and carrying out standardization processing on the symptom degree data to obtain standardized symptom degree data; calculating change values of the standardized traditional Chinese medicine dose data and the change values of the standardized symptom degree data in all visits in each case data and obtaining object data of each case data according to the relationship between the change values of the standardized traditional Chinese medicine dose data and the change values of the standardized symptom degree data; and mining the object data through an association rule data mining algorithm and obtaining an association rule of traditional Chinese medicine dose changes and symptom degree changes in all visits in each case data. According to the traditional Chinese medicine data processing device and method, effective statistics and analysis of the relationship between the traditional Chinese medicine dose changes and the symptom degree changes in multiple visits in the case data can be achieved.

The invention discloses a traditional Chinese medicine enema for treating ulcerative colitis, wherein traditional Chinese medical science holds that the ulcerative colitis belongs to the domain of 'diarrhoea', 'bloody stool' and 'dysentery', and the pathogenesis mostly is mainly caused by feeling six viruses of wind, cold, heat, dampness and dryness, having internal damage by excess of seven emotions and damaging spleen and stomach, constraining large intestine by the dampness and heat to obstruct the intestinal Qi function and injure the vein to cause blood and meat rot to emerge ulcer finally. Therefore, the traditional Chinese medicine enema provided by the invention chooses traditional Chinese medicines including japanese claw fern herb, caulis arcangelisiae, phellodendron bark, cordate houttuynia, folium glochidii eriocarpi, featherycleft horsegentian fruit, moutan bark, frankincense, bletilla striata, red halloysite and licorice root having functions of clearing away heat and toxicity, activating blood circulation and removing blood stasis and removing swelling and promoting granulation to process into the enema. After clinical tests in the hospital, the total efficiency reaches to 97.2%, the clinical symptom improvement is obviously superior to that of a contrast group, the side effect is low and the treatment cost is low. Therefore, the enema provided by the invention is suitable for clinical promotion and application.

The invention provides a compound maltodextrin fructose beverage. Each liter of compound maltodextrin fructose beverage comprises, by weight, 100-110 g of maltodextrin, 10-20 g of crystalline fructose, 2.0-3.0 g of sodium citrate, 3.0-4.0 g of potassium citrate, 0.1-0.2 g of sweetening agent, 0.2-0.3 g of vitamin C, pH modifier, and the balance water, wherein the dosage of the pH modifier follows the standard of making the pH of the compound maltodextrin fructose beverage be 4.7-5.0. The compound maltodextrin fructose beverage contains carbohydrates and vitamin C, the energy of the beverage is high, and the beverage is rich in nutrition. The invention further provides a method for preparing the compound maltodextrin fructose beverage. The preparation method is simple and easy to operate. The compound maltodextrin fructose beverage is suitable for being drunk by a patient before an operation, so that the patient's energy storage under the conditions of an empty stomach is improved, the carbohydrate metabolism is maintained, postoperation insulin resistance is reduced, pre-operation thirst, hunger and anxiety are relieved, the patient's postoperation subjective symptom improvement awareness is improved, the thin and weak patient's weight loss is reduced, and hospital stay is shortened.

The invention relates to a lollipop. The lollipop is prepared by using the following raw materials, by weight, 55-60 parts of brown sugar, 14-27 parts of maltose syrup, 3-20 parts of a dietary fiber component, 5-15 parts of a component with a blood enriching function, 0.1-0.2 parts of an essence component and 1-4 parts of a beauty treatment component. The most popular lollipop is adopted as a product dosage form in the invention, so the product is convenient and effective, can be used as a daily snack, and is a daily leisure delicious food with an anaemia symptom improvement function.

The present disclosure relates to compositions and methods for treating autism spectrum disorder (ASD) by restoring an ASD patient's gut microbiota. These methods can be used with ASD patient with orwithout ongoing gastrointestinal symptoms. Provided here is a method for ASD treatment in a subject in need thereof comprising or consisting essentially of administering a therapeutic composition comprising a fecal microbe or a fecal microbiota preparation to the subject. Also provided here is a method comprises administering an antibiotic to a human subject; subjecting the human subject to a bowel cleanse; and administering purified fecal microbiota to the human subject. Further provided are evaluation and quantitative characterization of patient symptom improvements upon treatment describedhere.

The invention discloses a medicament for treating functional dyspepsia. The medicament comprises an active component and a pharmaceutically acceptable excipient, wherein the active component is prepared from the following crude drugs in percentage by weight: 20-35 percent of purple perilla, 20-25 percent of immature citron fruit, 15-20 percent of zedoray rhizome, 15-20 percent of coptis chinensis and 15-20 percent of dried ginger. The medicament can be granules, capsules, tablets or pills. Through clinical verification, the medicament has the advantages of good symptom improvement, low relapse rate and no obvious toxic or side effect.

The invention discloses a medicament for treating functional dyspepsia. The medicament comprises an active component and a pharmaceutically acceptable excipient, wherein the active component is prepared from the following crude drugs in percentage by weight: 20-35 percent of purple perilla, 20-25 percent of immature citron fruit, 15-20 percent of zedoray rhizome, 15-20 percent of coptis chinensis and 15-20 percent of dried ginger. The medicament can be granules, capsules, tablets or pills. Through clinical verification, the medicament has the advantages of good symptom improvement, low relapse rate and no obvious toxic or side effect.

The invention discloses a drug for treating parkinson disease. The drug comprises effective ingredients and a medically acceptable excipient. The drug comprises effective ingredients comprising 20-26wt% of ginseng, 28-34wt% of prepared fleece flower root, 20-26wt% of ginkgo leaf and 20-26wt% of radix ophiopogonis. The drug is an oral preparation in a form of capsules, particles, condensed pills or tablets. A clinical use proves that the drug has the advantages of fast symptom improvement and short treatment course. The drug is prepared from less types of raw materials, can be prepared by simple and easy processes and has a wide application value.

The invention relates to a pharmaceutical composition for curing peripheral neuropathy of diabetes and a preparation method thereof. The composition of the invention mainly consists of Astragalus root, glossy privet fruit, cassia twig, radix paeoniae rubra, radix scutellariae, coptis root and leeches, is a medicine manufactured with a carrier or an exipient acceptable in pharmacy and in types of capsule, granule, tablet, soft capsule, guttate pill and the like. The composition of the invention has effects in supplementing qi, nourishing yin, detoxificating, dissolving the stagnant and activating channels, and is applicable to patients suffering from peripheral neuropathy of diabetes. The clinical research shows that the composition of the invention can obviously improve such symptoms of the patients suffering from peripheral neuropathy of diabetes as numbness of the limbs, sore limbs, warmlessness of acral, abnormal sensation, exhaustion and the like, as well as imposing an obvious improvement on nerve conducting speed and ending microcirculation. With the adoption of the composition of the invention, the sorbitol content in red blood cell decreases obviously, without any obvious untoward reaction.

The invention discloses DBS validity detection equipment based on a myoelectricity marker, and belongs to the technical field of data processing. Through a surface electromyogram analysis technology,tremor coefficients, rigidity coefficients and movement coefficients with myoelectricity as the core are innovatively put forward, the symptom improvement condition of a patient after DBS operative treatment can be objectively evaluated, the defect in validity judgment DBS treatment operation is overcome, a solid myoelectricity basis is laid for setting up a mechanism for treating Parkinson's diseases through DBS operation, the development of the portable equipment can improve the precision of the DBS operative treatment for the Parkinson's diseases, the conversion of clinical achievements ispromoted, and the blank of clinical markets is filled up.

The invention relates to blood pressure lowering capsules and a preparation process thereof, in particular to pagodatree flower bud-eucommia bark pulse pressure capsules and a preparation process thereof. The pagodatree flower bud-eucommia bark pulse pressure capsules consist of the following components in part by weight: 20 to 150 parts of cassia seed, 10 to 100 parts of pagodatree flower bud, 10 to 100 parts of hawthorn, 30 to 260 parts of dogbane leaf and 40 to 400 parts of eucommia bark leaf, wherein the components are prepared into particles by extracting, condensing and drying and are filled into the capsules. The blood pressure lowering capsules have the outstanding advantages of slow and stable pressure lowering effect on the treatment of hypertension, remarkable symptom improvement, small side effect, simple preparation process, small administration dose and quick absorption, are convenient to take, carry and store, are pure Chinese medicinal preparations and safe and effective pressure lowering medicaments, can be applied clinically for a long time and are particularly suitable for patient suffering from mild and moderate hypertension.

The invention discloses a tea cigarette and a preparation method thereof. The preparation method of the tea cigarette comprises that tea leaves are ground into powder, finished cigarette or cut tobacco and the tea powder obtained by grinding are placed in the same container for more than 10 days, or the cut tobacco is immersed in tea water for more than six hours to prepare the tea cigarette; when the cut tobacco is immersed in the tea water, 1-3g of the cut tobacco is immersed in 25-30ml of the tea water, and the tea water is prepared in a way that 35-65g of tea is immersed in 1L of boiled water. According to the invention, tea powder or tea water can absorb substance which is harmful to human health in finished cigarette or cut tobacco, and finished cigarette or cut tobacco can absorb beneficial components in tea, and therefore substance being harmful to human health in cigarettes can be reduced, the prepared tea cigarette has tea fragrance and contains beneficial components in tea, and the tea cigarette has affects of cancer-fighting, fat-reducing, lipid-lowering and smoker excessive phlegm symptom improvement.

Noninvasive natural healing in daily life or regenerative cell treatment can be promoted. A knee joint model is constructed by three-dimensionally analyzing measurement data obtained by measuring an outline shape and internal space shape of a knee joint part of a subject; a transition state towards an orthotic direction for a symptom improvement of the knee joint part is simulated continuously or stepwisely with reference to the knee joint model; and an exoskeleton mold capable of continuously or stepwisely finely adjusting the knee joint part towards the orthotic direction is designed based on the transition state.

The invention discloses a western medicine composition for treating gout and application of the western medicine composition. Active components of the western medicine composition include, by weight, 7-11 parts of tetrahydroserpentine, 5-9 parts of kaempferol and 8-12 parts of eugenol. Adult dosage is 0.4-0.48mg / kg / day. The western medicine composition which is prepared from tetrahydroserpentine, kaempferol and eugenol has advantages that by interaction of all components, gout symptom improvement and gout development delaying are remarkably and jointly realized, and accordingly healing of gout patients is facilitated, and the total clinical effective rate is 98-100%. The western medicine composition is low in dosage and has no evident adverse effects and toxic and side effects on human bodies, the problem of tolerance of gout treating medicines is effectively solved, and gout curative effects of the western medicine composition do not decline along with time.

The invention discloses a making method of dried bean curds capable of invigorating the stomach and nourishing the kidney. The making method comprises the following steps of (1) making bean curds: adding extraction concentrate and a gypsum solution to soybean milk for bean curds; (2) performing low-temperature fermentation: sprinkling a microbial inoculum solution onto the surfaces of the bean curds, and performing low-temperature fermentation; (3) pressing dried bean curds: wrapping the bean curds with gauze, placing the wrapped bean curds into a shaping die, and performing extrusion to obtain the dried bean curds; (4) performing freezing: performing storage in a thermotank of temperature being minus 7-minus 5 DEG C and minus 4- minus 2 DEG C, and performing baking so as to obtain the dried bean curds; (5) performing steaming: enabling the dried bean curds to roll in mixed nutrient powder and sweet-scented osmanthus mixed powder, performing wrapping with reed leaves, and performing steaming; and (6) performing vacuum packaging: performing vacuum packaging on the dried bean curds capable of invigorating the stomach and nourishing the kidney, and performing preservation. After the dried bean curds capable of invigorating the stomach and nourishing the kidney made by the making method disclosed by the invention are used by patients suffering from slight nephropathy, the nephropathy can be obviously improved, the symptom improvement rate is 90% or above, the effect of the dried bean curds is 27.5% higher than that of dried bean curds soaked with medicaments, and besides, the made dried bean curds are high in content of free amino acids and good in mouth feel and flavor.

The invention discloses compound soft-shell capsules with radix ophiopogonis. A method for preparing the compound soft-shell capsules includes extracting the radix ophiopogonis, radix asparagi, dried bitter gourd and water spinach by the aid of a supercritical extraction process to obtain extracts of polysaccharide concentrated solution of the radix ophiopogonis, extracts of polysaccharide concentrated solution of the radix asparagi, extracts of concentrated solution of momordica saponins and extracts of polysaccharide concentrated solution of the water spinach; blending the extracts to obtain mixed liquid; further blending the mixed liquid, ramie oil, soybean oil and walnut oil to obtain mixed oil; laying capsule shell materials made of edible gelatin in equipment; adding mixed oil to match with machines, manufacturing the soft-shell capsules according to design dosage by the aid of molds; sterilizing the soft-shell capsules; bottling the soft-shell capsules. The weight of each soft-shell capsule is 1g. The compound soft-shell capsules have the advantages that an adult takes 1-2 compound soft-shell capsules three times each day, so that the compound soft-shell capsules can have certain positive significance on activation, diabetes mellitus symptom improvement and complicated angionosis prevention.

A method for predicting a negative symptom change in a subject during drug therapy is provided. The method comprises isolating genomic DNA from a sample of the subject, and genotyping a T5988C marker of GRIN2B gene. A GRIN2B 5988 T / T genotype is predictive of a negative symptom improvement in the subject in response to drug therapy. The drug therapy may be clozapine therapy. Also provided is a method of identifying a polymorphism in a nucleotide sequence of interest that is predictive of response to drug therapy comprising the steps of assessing negative symptom improvement in a plurality of subjects during the course of drug therapy, isolating a sample comprising DNA from each subject, genotyping one or more nucleotide sequences of interest in the DNA of each subject to identify one or more polymorphisms that exist in the one or more nucleotide sequences of interest, wherein correlation of a significant improvement of negative symptoms with one or more polymorphisms is predictive of response to drug therapy.

The invention provides a medicine for interventional treatment of uterine myoma. The medicine belongs to a polyoxyethylene lauryl alcohol ether compound, called lauromacrogol for short; after lauromacrogol is injected under the envelope of an uterine myoma body, a layer of fibre textures is formed in the lower layer of the envelope; blood vessels are injured and permanently occluded by the fibre textures, so that the uterine myoma body is reduced and gradually disappears; uterine myoma is subjected to interventional treatment by utilizing the medicine, so that the functions of an uterus can be intactly retained; in addition, fertilization is not influenced; operative wound and a series of post-operative complications are avoided; the effect of the medicine disclosed by the invention is comparable with operation in the aspect of symptom improvement; by means of interventional treatment of uterine myoma by utilizing the medicine, the medicine disclosed by the invention is small in wound, rapid in recovery, free from being in hospital and easy for patients to accept; compared with the traditional operative treatment, interventional treatment of uterine myoma by utilizing the medicine is simple and convenient; furthermore, blood transfusion is generally unnecessary; the medicine disclosed by the invention has the advantages of being minimally invasive, repeatable, accurate for locating, high in curative effect, rapid in effect, few in complications and the like and brings a good development prospect for clinical treatment of uterine myoma.

The invention discloses a Chinese medicinal preparation for treating stubborn headache. About the pathogenesis of the stubborn headache, Chinese medicine considers that the headache can be caused when six evils attack, discomfort achieves the top of the head, pathogenic factors detain, lucid yang is blocked, or the headache can be caused by internal injury, disorder of qi and blood, meridian stasis and nourishment deficiency in brain. Chinese medicaments such as corydalis tuber, suberect spatholobus stem, five-leaf akebia fruit, pinellia cordata, scorpion, caltrop, antelope's horn, white peony root, human placenta, potentilla anserina, polygala root, longan aril and licorice are decocted by using water in the hospital to obtain decoction; through clinical test, the total effective rate reaches 96.3 percent and is obviously superior to that of a contrast group; and the preparation is quick in response, obvious in symptom improvement, stable in curative effect and worthy of clinical popularization and application.

The invention provides a hypotensive and lipid-reducing chastetree fruit healthcare oral solution. The oral solution is composed of, by weight, 10-50 parts of chastetree fruit, 10-20 parts of uncaria, 10-20 parts of motherwort, 10-20 parts of white wolfberry root, 10-20 parts of cassia seed, 10-20 parts of fiveleaf gynostemma herb, 10-20 parts of red-rooted salvia root, 10-20 parts of szechwan lovage rhizome, 10-20 parts of cape jasmine fruit, 10-20 parts of prepared fleece-flower root, 10-20 parts of Chinese taxillus herb, 10-20 parts of sophorae fruit, 10-20 parts of Chinese magnoliavine fruit, 10-20 parts of epimedium herb, 10-20 parts of herba siegesbeckiae, 10-20 parts of corni fruit, 10-20 parts of harlequin glorybower leaf and 10-20 parts of white peony root. Different from Western medicine which expands blood vessels to temporarily lower blood pressure for symptom improvement, the oral solution which is traditional Chinese medicine fundamentally solves the problem of hypertension.

The invention discloses a thrombolytic drug, relates to the field of traditional Chinese medicine preparations, and aims to solve the problems that an existing traditional Chinese medicine preparationis poor in treatment effect on thrombus, particularly cerebral thrombosis treatment effect and symptom improvement effect, and an existing thrombus removal device is rarely combined with an auxiliarythrombus removal agent for use. The thrombolytic drug is prepared from 30-60 parts of radix salviae miltiorrhizae, 15-30 parts of ramulus uncariae cum uncis, 15-25 parts of herba siegesbeckiae, 15-25parts of spica prunellae, 10-15 parts of lumbricus, 10-15 parts of flos carthami, 15-25 parts of semen persicae, 15-25 parts of ramulus mori, 15-25 parts of orange twig, 15-25 parts of pine twig, 15-25 parts of peach twig, 15-25 parts of fir twig. 25 parts of bamboo branches and 2-5 parts of radix glycyrrhizae. The invention is applied to treatment of thrombotic diseases.

The invention belongs to the technical field of microorganisms and relates to application of probiotic mixture Nagqu 4580 in foods to improve sleep quality. After taking Nagqu 4580 for two weeks, thesleep conditions of people of different agents are evidently improved; with the time of taking Nagqu 4580 getting longer, the improvement effect is better; the improvement rate is 93% and above; administration days focus to 3-4 days; in terms of symptom improvement, sleep latency is shorter, sleep time is extended, and the symptoms can be improved, such as waking up at midnight.

The invention discloses a traditional Chinese medicine composition for treatment of obesity. The traditional Chinese medicine composition comprises effective preparation materials including 5-20g of Pericarpium Citri Reticulatae, 5-20g of Rhizoma Pinelliae, 10-25g of Poria Cocos, 2-10g of Radix Glycyrrhizae, 5-15g of Radix Aucklandiae, 5-15g of Rhizoma Atractylodis, 5-15g of Rhizoma Atractylodis Macrocephalae, 3-16g of Rhizoma Cyperi, 4-12g of Rhizoma Ligustici Wallichii and 6-16g of Radix Angelicae Sinensis. The traditional Chinese medicinal materials are soaked for 30min, decocted over strong fire for 20min and then decocted over warm fire for 20min, and obtained decoction is supposed to be taken warm twice a day and preferably taken in the afternoon and 30min before sleep at night respectively. The adopted materials are all Chinese herbal medicines, Rhizoma Atractylodis has efficacies of damp drying and spleen strengthening, Radix Aucklandiae has an efficacy of Qi circulation promoting; Rhizoma Cyperi has efficacies of liver soothing and Qi regulating, Rhizoma Ligustici Wallichii has efficacies of blood activating and Qi circulation promoting, and Radix Angelicae Sinensis has efficacies of blood replenishing and blood circulation promoting. The traditional Chinese medicine composition is great in treatment effect, low in raw material cost and effective in obesity symptom improvement.

The invention relates to a ginsenoside Rb3 composition and an application thereof in preparing a medicament for treating diabetes. The ginsenoside Rb3 composition is prepared from ginsenoside Rb3 as a main component and 1-5 of a carrier, an excipient, a sweetening agent, an adhesive, a flavoring agent, a preservative, a dispersing agent, a surfactant and a colorant as adjuvants, and the medicament is prepared into tablets, pills, granules, capsules and powder. The method for extracting the ginsenoside Rb3 comprises the following steps: dissolving crude extracts of stems and leaves of American ginseng, ginseng or pseudo-ginseng in water, then separating by NKA-12 macroporous resin, and performing gradient elution by ethanol water to obtain panaxatriol saponin and panaxadiol saponin. Repeated chromatography is preformed on the panaxadiol saponin by silicagel columns to obtain pure ginsenoside Rb3 with the purity of 98%. Proven by animal experiments, the ginsenoside Rb3 has notable effects of symptom improvement and treatment on diabetes and adiposis.

The invention relates to the technical field of medical care, and discloses a depression patient symptom improvement degree recording and analyzing device which comprises a display module, a broadcasting module, a terminal control module and an information input system, the display module and the broadcasting module are both in signal connection with the terminal control module, and the information input system is used for inputting external information of a depression patient. The information input system is in signal connection with an information processing system; the information processing system is used for receiving information contents transmitted by the information input system; according to the depression patient symptom improvement degree recording and analyzing device, through consideration of information in multiple aspects, the judgment factors of the depression patient symptom improvement degree are effectively increased, the influence of accident factors is reduced, and therefore the accuracy of judgment of the depression patient symptom improvement degree is guaranteed; systematization and standardization of symptom improvement degree evaluation of depression patients are guaranteed, the influence of subjective consciousness of doctors is reduced, and the judgment accuracy of the device is further improved.

The invention provides a blood pressure regulation medicine mainly using rhodiola rosea. The blood pressure regulation medicine comprises the following raw materials in parts by weight: 200-250 parts of rhodiola rosea, 100-200 parts of selfheal, 50-100 parts of chrysanthemum, 250-350 parts of astragalus membranaceus, 100-150 parts of semen cassiae, 80-150 parts of wolfberry, 150-250 parts of lily flowers, 100-200 parts of radix rehmanniae, 200-300 parts of codonopsis pilosula, 100-250 parts of common yam rhizome, 4-8 parts of fructus amomi and 40-60 parts of red dates. A preparation method of the medicine provided by the invention comprises the following steps: soaking the medicines in water at room temperature for 3-4 hours, then decocting for 90-120 minutes under a gauge pressure of 0.09-1.1MPa, then repeatedly adding water and decocting for 50-80 minutes and for twice under the gauge pressure of 0.09-1.1MPa, then adding fructus amomi, combining the decoctions of the three times and then sub-packaging into 25 parts. Compared with the prior art, the medicine provided by the invention is improved by about 2% and 11% in the aspects of reducing pressure and improving symptoms respectively, and better in effect in case of being combined with western medicine treatment.

A fundamental shortcoming in the current treatment of schizophrenia is the lack of valid criteria to predict who will respond to antipsychotic treatment. The identification of blood-based biological markers of the therapeutic response would enable clinicians to identify the subgroup of patients in whom conventional antipsychotic treatment is ineffective and offer alternative treatments. As part of the Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) programme, the inventors conducted a transcriptome analysis on 188 subjects with first episode psychosis, all of whom were subsequently treated with amisulpride for 4 weeks. They identify 32 genes for which the expression changed after treatment in good responders only. Among these genes, the expression of ALPL, a gene involved in vitamin B6 metabolism, as well as CA4, DGTA2, DHRS13, HOMER3 and WLS showed a significant difference in expression level between good and poor responders before starting treatment, allowing to predict treatment outcome with a predictive value of 93.8% when combined with clinical features Collectively, these findings identified new mechanisms to explain symptom improvement after amisulpride medication and highlight the potential of combining gene-expression profiling with clinical data to predict treatment response in first episode psychoses.

The invention discloses health care wine preventing and curing rheumatism and rheumatoid. The health care wine is prepared from the following raw materials of, in parts by weight, 450-550 parts of fresh honey bee pupae, 80-120 parts of honey, 10-30 parts of roots of bidentate achyranthes, 10-30 parts of prepared radix rehmanniae, 15-40 parts of radix ophiopogonis, 10-28 parts of rhizoma polygonati, 15-35 parts of dried radix rehmanniae and 10-30 parts of cortex lycii radicis. The invention further discloses a preparation method of the health care wine preventing and curing rheumatism and rheumatoid. The health care wine is clear and transparent, fragrant and mild, rich in bouquet, and soft and sweet in taste, has the efficacy of tonifying the liver and kidneys, nourishing the blood to expel wind and dampness, promoting blood circulation to remove blood stasis and activating meridians to stop pain, can promote circulation of blood and postpone ageing, and meanwhile, has the outstandingeffects of symptom improvement and treatment on rheumatism and rheumatoid, and the health care wine has the characteristics that the curative effect is accurate, the treatment time is short, no toxicand side effect is caused, the health care wine is healthy and nutrient, safe and reliable, and beneficial for health if being taken for a long term.